Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kevin Park

Showing results (1-10 of 282) with videos related to

Pageof 29
Sort By:
British Journal of Clinical Pharmacology|May 21, 2003
Adverse drug reactions: back to the futureMunir Pirmohamed, B Kevin Park
Toxicology|September 27, 2003
Cytochrome P450 enzyme polymorphisms and adverse drug reactionsMunir Pirmohamed, B Kevin Park
Drug Discovery Today|December 24, 2003
Idiosyncratic toxicity: the role of toxicophores and bioactivationDominic P Williams, B Kevin Park
The Journal of Allergy and Clinical Immunology|August 9, 2015
New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityMunir Pirmohamed, David A Ostrov, B Kevin Park
Current Allergy and Asthma Reports|January 25, 2003
Immunopharmacology of hypersensitivity reactions to drugsDean J Naisbitt, Munir Pirmohamed, B Kevin Park
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 8, 2015
Parsing interindividual drug variability: an emerging role for systems pharmacologyRichard M Turner, B Kevin Park, Munir Pirmohamed
Expert Opinion on Drug Safety|March 21, 2007
Immunological principles of T-cell-mediated adverse drug reactions in skinDean J Naisbitt, Munir Pirmohamed, B Kevin Park
Current Opinion in Drug Discovery & Development|February 3, 2007
Biomarkers: the pièce de résistance of innovative medicinesDale E Johnson, Dennis A Smith, B Kevin Park
Current Opinion in Drug Discovery & Development|January 20, 2009
Pharmacogenomics and adverse drug reactions; prospective screening for risk identificationDale E Johnson, Dennis A Smith, B Kevin Park
The AAPS Journal|April 6, 2006
Role of bioactivation in drug-induced hypersensitivity reactionsJoseph P Sanderson, Dean J Naisbitt, B Kevin Park
Pageof 29

Showing results (1-10 of 282) with videos related to

Sort By:
Pageof 29
British Journal of Clinical Pharmacology|May 21, 2003
Adverse drug reactions: back to the futureMunir Pirmohamed, B Kevin Park
Toxicology|September 27, 2003
Cytochrome P450 enzyme polymorphisms and adverse drug reactionsMunir Pirmohamed, B Kevin Park
Drug Discovery Today|December 24, 2003
Idiosyncratic toxicity: the role of toxicophores and bioactivationDominic P Williams, B Kevin Park
The Journal of Allergy and Clinical Immunology|August 9, 2015
New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityMunir Pirmohamed, David A Ostrov, B Kevin Park
Current Allergy and Asthma Reports|January 25, 2003
Immunopharmacology of hypersensitivity reactions to drugsDean J Naisbitt, Munir Pirmohamed, B Kevin Park
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|May 8, 2015
Parsing interindividual drug variability: an emerging role for systems pharmacologyRichard M Turner, B Kevin Park, Munir Pirmohamed
Expert Opinion on Drug Safety|March 21, 2007
Immunological principles of T-cell-mediated adverse drug reactions in skinDean J Naisbitt, Munir Pirmohamed, B Kevin Park
Current Opinion in Drug Discovery & Development|February 3, 2007
Biomarkers: the pièce de résistance of innovative medicinesDale E Johnson, Dennis A Smith, B Kevin Park
Current Opinion in Drug Discovery & Development|January 20, 2009
Pharmacogenomics and adverse drug reactions; prospective screening for risk identificationDale E Johnson, Dennis A Smith, B Kevin Park
The AAPS Journal|April 6, 2006
Role of bioactivation in drug-induced hypersensitivity reactionsJoseph P Sanderson, Dean J Naisbitt, B Kevin Park
Pageof 29